Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Harp

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Connecticut Medicine|February 18, 1998
State leadership perspectiveG L Gunther, T Harp
Handbook of Clinical Neurology|February 11, 2014
The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatmentAndrew P Robinson, Christopher T Harp, Avertano Noronha, et al.
Journal of Autoimmunity|March 22, 2013
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitisAndrew P Robinson, Matthew W Caldis, Christopher T Harp, et al.
Clinical Immunology (Orlando, Fla.)|July 5, 2008
Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosisChristopher T Harp, Amy E Lovett-Racke, Michael K Racke, et al.
Autoimmunity|March 22, 2012
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacitySara J Ireland, Monica Blazek, Christopher T Harp, et al.
ACS Nano|February 25, 2014
A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune diseaseZoe Hunter, Derrick P McCarthy, Woon Teck Yap, et al.
Cellular Immunology|May 28, 2014
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitisSarah E Blink, Matthew W Caldis, Gwendolyn E Goings, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 11, 2016
An antigen-encapsulating nanoparticle platform for T<sub>H</sub>1/17 immune tolerance therapyDerrick P McCarthy, Jonathan Woon-Teck Yap, Christopher T Harp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune DiseaseRyan C Winger, Christopher T Harp, Ming-Yi Chiang, et al.
Genes and Immunity|April 19, 2013
Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutationA J Ligocki, W H Rounds, E M Cameron, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Connecticut Medicine|February 18, 1998
State leadership perspectiveG L Gunther, T Harp
Handbook of Clinical Neurology|February 11, 2014
The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatmentAndrew P Robinson, Christopher T Harp, Avertano Noronha, et al.
Journal of Autoimmunity|March 22, 2013
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitisAndrew P Robinson, Matthew W Caldis, Christopher T Harp, et al.
Clinical Immunology (Orlando, Fla.)|July 5, 2008
Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosisChristopher T Harp, Amy E Lovett-Racke, Michael K Racke, et al.
Autoimmunity|March 22, 2012
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacitySara J Ireland, Monica Blazek, Christopher T Harp, et al.
ACS Nano|February 25, 2014
A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune diseaseZoe Hunter, Derrick P McCarthy, Woon Teck Yap, et al.
Cellular Immunology|May 28, 2014
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitisSarah E Blink, Matthew W Caldis, Gwendolyn E Goings, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 11, 2016
An antigen-encapsulating nanoparticle platform for T<sub>H</sub>1/17 immune tolerance therapyDerrick P McCarthy, Jonathan Woon-Teck Yap, Christopher T Harp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune DiseaseRyan C Winger, Christopher T Harp, Ming-Yi Chiang, et al.
Genes and Immunity|April 19, 2013
Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutationA J Ligocki, W H Rounds, E M Cameron, et al.
Pageof 2